Modern medicine stands at the threshold of a computational renaissance, where biological complexity meets algorithmic sophistication to unlock unprecedented therapeutic possibilities. As healthcare systems confront rising costs and limited treatment options for complex diseases, generative AI in pharma emerges as the cornerstone of a new therapeutic paradigm, fundamentally altering our...